SEC Form 4 · accession 0000899243-16-010873
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Ambrogi
Officer — Chief Operating Officer
Period of report
Jan 4, 2016
Accepted (ET)
Jan 5, 2016 · 5:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jan 4, 2016 | M | 332,984 | $0.17 | A | 334,084 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Buy Ordinary SharesF1 | $0.17 | Jan 4, 2016 | M | 332,984 | D | — | Jul 1, 2016 | Ordinary Shares | 332,984 | 0 | D |
Explanation of responses
- F1Fully vested and currently exercisable as of the date hereof.